Metastatic Castration-Resistant Prostate Cancer (mCRPC) trials recruiting in Pennsylvania

All Metastatic Castration-Resistant Prostate Cancer (mCRPC) trials nationally

Cities in Pennsylvania

Recruiting trials in Pennsylvania

• A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
  NCT06136650 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Bala-Cynwyd, Philadelphia
• A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
  NCT03972657 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia
• Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
  NCT06134232 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Pennsylvania: Bala-Cynwyd, Lancaster
• Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
  NCT05176483 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Hershey, Philadelphia, Pittsburgh
• Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
  NCT07493512 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Pennsylvania: Philadelphia, Pittsburgh